Logo image of IQV

IQVIA HOLDINGS INC (IQV) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IQV - US46266C1053 - Common Stock

226.92 USD
+0.9 (+0.4%)
Last: 12/26/2025, 8:04:00 PM
226.92 USD
0 (0%)
After Hours: 12/26/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IQV. IQV was compared to 57 industry peers in the Life Sciences Tools & Services industry. IQV scores excellent on profitability, but there are concerns on its financial health. IQV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IQV was profitable.
IQV had a positive operating cash flow in the past year.
IQV had positive earnings in each of the past 5 years.
IQV had a positive operating cash flow in each of the past 5 years.
IQV Yearly Net Income VS EBIT VS OCF VS FCFIQV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

IQV has a Return On Assets of 4.47%. This is in the better half of the industry: IQV outperforms 78.95% of its industry peers.
With an excellent Return On Equity value of 20.83%, IQV belongs to the best of the industry, outperforming 91.23% of the companies in the same industry.
IQV's Return On Invested Capital of 9.77% is amongst the best of the industry. IQV outperforms 85.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IQV is below the industry average of 13.99%.
The last Return On Invested Capital (9.77%) for IQV is above the 3 year average (8.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.47%
ROE 20.83%
ROIC 9.77%
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
IQV Yearly ROA, ROE, ROICIQV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With a decent Profit Margin value of 8.07%, IQV is doing good in the industry, outperforming 77.19% of the companies in the same industry.
IQV's Profit Margin has improved in the last couple of years.
IQV has a better Operating Margin (14.20%) than 77.19% of its industry peers.
In the last couple of years the Operating Margin of IQV has grown nicely.
IQV has a Gross Margin of 33.78%. This is in the lower half of the industry: IQV underperforms 64.91% of its industry peers.
IQV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.2%
PM (TTM) 8.07%
GM 33.78%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
IQV Yearly Profit, Operating, Gross MarginsIQV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IQV is destroying value.
Compared to 1 year ago, IQV has less shares outstanding
Compared to 5 years ago, IQV has less shares outstanding
The debt/assets ratio for IQV is higher compared to a year ago.
IQV Yearly Shares OutstandingIQV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IQV Yearly Total Debt VS Total AssetsIQV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

IQV has an Altman-Z score of 2.07. This is not the best score and indicates that IQV is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of IQV (2.07) is comparable to the rest of the industry.
The Debt to FCF ratio of IQV is 6.76, which is on the high side as it means it would take IQV, 6.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.76, IQV is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
IQV has a Debt/Equity ratio of 2.08. This is a high value indicating a heavy dependency on external financing.
IQV has a Debt to Equity ratio of 2.08. This is amonst the worse of the industry: IQV underperforms 85.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.08
Debt/FCF 6.76
Altman-Z 2.07
ROIC/WACC0.93
WACC10.49%
IQV Yearly LT Debt VS Equity VS FCFIQV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

IQV has a Current Ratio of 0.70. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.70, IQV is not doing good in the industry: 92.98% of the companies in the same industry are doing better.
IQV has a Quick Ratio of 0.70. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.70, IQV is not doing good in the industry: 91.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
IQV Yearly Current Assets VS Current LiabilitesIQV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.09% over the past year.
IQV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.72% yearly.
IQV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.85%.
The Revenue has been growing slightly by 6.80% on average over the past years.
EPS 1Y (TTM)7.09%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%5.63%
Revenue 1Y (TTM)3.85%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.24%

3.2 Future

The Earnings Per Share is expected to grow by 10.39% on average over the next years. This is quite good.
Based on estimates for the next years, IQV will show a small growth in Revenue. The Revenue will grow by 5.88% on average per year.
EPS Next Y7.78%
EPS Next 2Y8.36%
EPS Next 3Y9.19%
EPS Next 5Y10.39%
Revenue Next Year5.28%
Revenue Next 2Y5.33%
Revenue Next 3Y5.47%
Revenue Next 5Y5.88%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IQV Yearly Revenue VS EstimatesIQV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
IQV Yearly EPS VS EstimatesIQV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.51, the valuation of IQV can be described as rather expensive.
Based on the Price/Earnings ratio, IQV is valued cheaply inside the industry as 89.47% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.92. IQV is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 17.35, the valuation of IQV can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IQV indicates a rather cheap valuation: IQV is cheaper than 94.74% of the companies listed in the same industry.
IQV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.46, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.51
Fwd PE 17.35
IQV Price Earnings VS Forward Price EarningsIQV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IQV indicates a rather cheap valuation: IQV is cheaper than 85.96% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IQV is valued cheaper than 91.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.48
EV/EBITDA 15.19
IQV Per share dataIQV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IQV does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of IQV may justify a higher PE ratio.
PEG (NY)2.51
PEG (5Y)1.66
EPS Next 2Y8.36%
EPS Next 3Y9.19%

0

5. Dividend

5.1 Amount

No dividends for IQV!.
Industry RankSector Rank
Dividend Yield 0%

IQVIA HOLDINGS INC

NYSE:IQV (12/26/2025, 8:04:00 PM)

After market: 226.92 0 (0%)

226.92

+0.9 (+0.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners100.7%
Inst Owner Change-2.37%
Ins Owners0.86%
Ins Owner Change-0.03%
Market Cap38.64B
Revenue(TTM)15.90B
Net Income(TTM)1.28B
Analysts83.45
Price Target258.38 (13.86%)
Short Float %3.29%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.2%
Min EPS beat(2)-0.04%
Max EPS beat(2)0.45%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-0.62%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)0.59%
EPS beat(16)12
Avg EPS beat(16)1.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.01%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)0.4%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)0.07%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)6
Avg Revenue beat(16)-0.16%
PT rev (1m)2.49%
PT rev (3m)17.38%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)-0.1%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)0.21%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 19.51
Fwd PE 17.35
P/S 2.43
P/FCF 17.48
P/OCF 13.78
P/B 6.27
P/tB N/A
EV/EBITDA 15.19
EPS(TTM)11.63
EY5.13%
EPS(NY)13.08
Fwd EY5.76%
FCF(TTM)12.98
FCFY5.72%
OCF(TTM)16.47
OCFY7.26%
SpS93.39
BVpS36.17
TBVpS-85.11
PEG (NY)2.51
PEG (5Y)1.66
Graham Number97.29
Profitability
Industry RankSector Rank
ROA 4.47%
ROE 20.83%
ROCE 11.17%
ROIC 9.77%
ROICexc 10.83%
ROICexgc N/A
OM 14.2%
PM (TTM) 8.07%
GM 33.78%
FCFM 13.9%
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
ROICexc(3y)9.76%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.28%
ROCE(5y)8.4%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y16.83%
ROICexc growth 5Y22.05%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 2.08
Debt/FCF 6.76
Debt/EBITDA 3.78
Cap/Depr 52.48%
Cap/Sales 3.73%
Interest Coverage 250
Cash Conversion 82.76%
Profit Quality 172.33%
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 2.07
F-Score5
WACC10.49%
ROIC/WACC0.93
Cap/Depr(3y)57.12%
Cap/Depr(5y)53.97%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.59%
Profit Quality(3y)136.6%
Profit Quality(5y)225.89%
High Growth Momentum
Growth
EPS 1Y (TTM)7.09%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%5.63%
EPS Next Y7.78%
EPS Next 2Y8.36%
EPS Next 3Y9.19%
EPS Next 5Y10.39%
Revenue 1Y (TTM)3.85%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.24%
Revenue Next Year5.28%
Revenue Next 2Y5.33%
Revenue Next 3Y5.47%
Revenue Next 5Y5.88%
EBIT growth 1Y4.3%
EBIT growth 3Y17.1%
EBIT growth 5Y21.64%
EBIT Next Year21.31%
EBIT Next 3Y11.05%
EBIT Next 5Y9.71%
FCF growth 1Y67.37%
FCF growth 3Y-2.8%
FCF growth 5Y20.42%
OCF growth 1Y42.92%
OCF growth 3Y-2.63%
OCF growth 5Y13.9%

IQVIA HOLDINGS INC / IQV FAQ

Can you provide the ChartMill fundamental rating for IQVIA HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to IQV.


What is the valuation status for IQV stock?

ChartMill assigns a valuation rating of 6 / 10 to IQVIA HOLDINGS INC (IQV). This can be considered as Fairly Valued.


Can you provide the profitability details for IQVIA HOLDINGS INC?

IQVIA HOLDINGS INC (IQV) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for IQV stock?

The Earnings per Share (EPS) of IQVIA HOLDINGS INC (IQV) is expected to grow by 7.78% in the next year.


Can you provide the dividend sustainability for IQV stock?

The dividend rating of IQVIA HOLDINGS INC (IQV) is 0 / 10 and the dividend payout ratio is 0%.